IPO Plus

₹133.6

▼ -5.21 -3.75%

As of 06 Nov 2026 · delayed

BSE Listed

Aspira Pathlab & Diagnostics Ltd. (540788)

Volume: 1,333Avg Vol 1W: 2,106Avg Vol 1M: 1,45652W Range:₹49₹149.99
BSE www.aspiradiagnostics.com AI Report
Key Ratios
Checked just now
Market Cap₹138 Cr
Current Price₹133.6
Previous Close₹138.81
High / Low (52w)₹149.99 / ₹49
Volume1,333
Avg Vol (1W)2,106
Avg Vol (1M)1,456
Stock P/E57.34
Book Value₹7.03
Dividend Yield0%
ROE16.62%
ROA13.75%
Revenue (TTM)—
Revenue Growth—
Profit Margin10.61%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹2.33
P/B19
Debt / Equity0.15
50 DMA₹116.01
200 DMA₹92.67
Day change-3.75%
Price Chart
₹133.6▲ 122.67% · 1Y
₹143₹541.4L
2025-11-06
2026-11-06

20-day avg volume: 2K shares

Pros
  • Healthy return on equity of 16.6%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 57.
Quarterly Results
MetricJun 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025
Revenue₹3 Cr₹4 Cr₹5 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr
EBITDA₹-1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹0 Cr
Net Profit₹-1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹0 Cr
EPS———————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹5 Cr₹22 Cr₹6 Cr₹5 Cr₹8 Cr₹5 Cr₹7 Cr₹6 Cr
EBITDA₹0 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹-1 Cr₹-1 Cr₹0 Cr
Net Profit₹0 Cr₹2 Cr₹1 Cr₹0 Cr₹2 Cr₹-2 Cr₹-1 Cr₹0 Cr
EPS—1.97——————
Balance Sheet
MetricMar 2024Mar 2025
Total Assets₹15 Cr₹17 Cr
Total Liabilities₹5 Cr₹5 Cr
Equity₹10 Cr₹12 Cr
Total Debt——
Cash Flow
MetricMar 2024Mar 2025
Operating₹1 Cr₹2 Cr
Investing₹0 Cr₹0 Cr
Financing₹-1 Cr₹-1 Cr
Free Cash Flow₹1 Cr₹2 Cr
Shareholding
Promoter 46.65% Institutions 0% Public 53.35%
Efficiency & Working Capital
ROCE13.2%
Interest Coverage6.8
Dividend Payout—
Debtor Days39 d
Inventory Days8 d
Payable Days12 d
Cash Conversion Cycle35 d
Working Capital Days48 d
Shareholding Details

As of 2026-09-30

Promoter46.6%
FII0%
DII0%
Institutions0%
Public53.4%
Promoter Pledge0%
No. of Shareholders1,603
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters18.9%18.7%18.7%18.5%18.5%18.4%18.4%18.4%18.4%18.4%46.6%46.6%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public81.1%81.3%81.3%81.5%81.5%81.6%81.6%81.6%81.6%81.6%53.4%53.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,3511,5121,6951,7061,5931,7411,7701,7551,7841,7691,6201,603
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Arvind Karsandas BhanushaliShareholding of Promoter and Promoter Group13.8%14,19,414
Deepali Arvind BhanushaliShareholding of Promoter and Promoter Group9.4%9,70,943
Aditya AgrawalPublic Shareholding7.4%7,60,921
Jay Arvind BhanushaliShareholding of Promoter and Promoter Group7.3%7,50,897
Nikunj Velji MangeShareholding of Promoter and Promoter Group7.1%7,31,896
Raj Arvind BhanushaliShareholding of Promoter and Promoter Group7%7,17,638
Rajesh Premji BhanushaliPublic Shareholding5.5%5,67,699
Pankaj Jashwant ShahPublic Shareholding4.9%5,00,000
Pooja Rajesh BhanushaliPublic Shareholding3.6%3,70,269
Manas ModiPublic Shareholding3.4%3,45,345
Amit ModiPublic Shareholding2.9%3,00,849
Puspahas AgrawalPublic Shareholding2.8%2,88,268
Ram Awtar RamsisariaPublic Shareholding2.4%2,46,715
Manoj RamsisariaPublic Shareholding2%2,05,099
Shradha RamsisariaPublic Shareholding1.5%1,51,566
Shraddha Jagdish BhanushaliShareholding of Promoter and Promoter Group1.5%1,50,262
Saakshi GuptaPublic Shareholding1.4%1,44,387
Paresh Bhanji BhanushaliShareholding of Promoter and Promoter Group0.4%43,999
Ruxmani Jayant BhansaliShareholding of Promoter and Promoter Group0.2%16,200
Yashraj Biotechnology LimitedShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Haseeb A DrabuChairman & Independent Directo2025
Pankaj Jashwant ShahManaging Director & CEO2025
Nikunj MangeManaging Director2025
Manas MengarIndependent Non Exe. Director2025
Krupali ShahCompany Sec. & Compli. Officer2025
Kiran Raghavendra AwasthiAddtnl Independent Director2025
Vaibhav OdhekarAdditional Director & E D2025
Segments — Geography
RegionRevenueShare
India₹25 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10201010
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000202
20260000-0-0
2026000202
Insider / Designated-Person Trades

12 recent disclosure(s)

Jay Arvind BhanushaliAcquisition · 245
Jay Arvind BhanushaliAcquisition · 1,424
Jay Arvind BhanushaliAcquisition · 1,387
Jay Arvind BhanushaliAcquisition · 74
Jay Arvind BhanushaliAcquisition · 957
Jay Arvind BhanushaliAcquisition · 623
Substantial Acquisitions (SAST)

8 disclosure(s)

Market28/09/2026 · 245
Market17/09/2026 - 24/09/2026 · 1,424
Market11/09/2026 - 16/09/2026 · 1,387
Market10/09/2026 · 74
Open Offer08/06/2026 · 22,82,507
Open Offer08/06/2026 · 22,82,507
Company Information
Incorporated1973
ChairmanHaseeb A Drabu
AuditorSarda Soni Associates LLP
Investor Email[email protected]
🌐 www.aspiradiagnostics.com ↗

📍 Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W), Mumbai, Maharashtra, 400086

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Nippon Life India AMCMahindra LogisticThe New India Assurance CompanyHDFC Life InsuranceSanghvi Brands LimitedSharika Enterprises LimitedDiligent Media CorporationRatnabhumi Developers LimitedMRC Agrotech LimitedDiggi Multitrade LimitedCrystal Business System LimitedAstron Paper & Board Mill Ltd.All “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App